Palbociclib in Older Patients with Advanced/Metastatic Breast Cancer: A Systematic Review

ConclusionsIn this systematic review, data from RCTs showed that palbociclib was effective, well tolerated, and maintained QoL in older patients with HR+/HER2 − a/mBC. Palbociclib treatment in older patients in real-world settings was associated with similar clinical benefit as in RCTs.PROSPERO RegistrationCRD42023444195.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research